United States · FDA National Drug Code directory

Pepto-Bismol Ultra

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
37000-440_4cd8234a-041b-a9e9-e063-6394a90ac431
Product NDC
37000-440
Form
SUSPENSION
Composition / generic term
Bismuth subsalicylate
Labeler
The Procter & Gamble Manufacturing Company
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20180301
Source listing expiry
20271231

Source-listed ingredients

  • BISMUTH SUBSALICYLATE — 525 mg/15mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 118 mL in 1 BOTTLE, PLASTIC (37000-440-04) · 37000-440-04
  • 236 mL in 1 BOTTLE, PLASTIC (37000-440-08) · 37000-440-08
  • 354 mL in 1 BOTTLE, PLASTIC (37000-440-12) · 37000-440-12
  • 3 BOTTLE, PLASTIC in 1 CELLO PACK (37000-440-36) / 354 mL in 1 BOTTLE, PLASTIC · 37000-440-36

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →